USPTO serial 76377042
GENOMICS ENABLER
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCMORROW, RONALD G
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GENOMICS ENABLER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William F. Lawrence
WILLIAM F LAWRENCE FROMMER LAWRENCE & HAUG LLP745 FIFTH AVENEW YORK, NY 10151UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the manufacture of pharmaceuticals; diagnostic preparations for scientific and research use | ABANDONED | — |
| 005 | Pharmaceutical preparations for use in treating heart and circulation conditions, autoimmune diseases, pancreatic diseases, diabetes, diseases of the central nervous system, and for preventing transplant rejection; pharmaceutical preparations containing therapeutic proteins, gene, and/or stem cells for use in the treatment of cellular or tissue related deficiencies; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; veterinarian vaccines for livestock and domestic animals | ABANDONED | — |
| 042 | Services of chemical, pharmaceutical, biotechnological and/or gene-technological laboratories; consulting in the fields of chemistry, pharmacy, biotechnology and/or gene-technology, providing information on a global network in the field of chemistry, pharmacy, biotechnology and/or gene-technology; research and development for new products for others in the fields of chemical, pharmaceutical, biotechnological and/or gene-technological products and preparations | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 16, 2003 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Aug 18, 2003 | PAPER RECEIVED | — | |
| Jun 5, 2003 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 27, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 7, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 11, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 7, 2003 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jan 29, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 6, 2002 | PAPER RECEIVED | — | |
| Jun 14, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2002 | DOCK | ASSIGNED TO EXAMINER | — |